Passive Smoking in Childhood Associated With Increased Risk for Adult Fatty Liver
Investigators assessed the relationship between passive smoking in children and adults with adult risk for fatty liver.
General Medicine
FDA Expert Panel to Weigh Approval of Moderna, Johnson & Johnson Booster Shots
Panel will consider whether third Moderna shot should contain half the original dose, best timing for second shot of single-dose J&J vaccine.
FDA Panel Supports Moderna Booster Shot for Older Adults, People at High Risk
An expert advisory panel to the U.S. Food and Drug Administration on Thursday recommended a half-dose booster shot of the Moderna vaccine be given to certain recipients six months after their second shot.
Protection Against SARS-CoV-2 Wanes Months After BNT162b2 Vaccination
Declines seen in humoral responses, effectiveness against SARS-CoV-2 infection, within several months after the second dose.
COVID-19 Delta Variant Tied to More Hospitalizations in Pregnant Patients
One-fourth of pregnant patients diagnosed at a public Texas hospital between Aug. 29 and Sept. 4 admitted for severe illness.
Merck Asks FDA to Approve First COVID-19 Antiviral Pill
Molnupiravir could be major advance because it reaches more high-risk patients than the monoclonal antibody treatments now being used.
FDA Questions Strength of Johnson and Johnson Booster Shot Data
Agency says key test used by the company to measure immune response from booster shot six months after the original shot likely not sensitive enough.
Impact of Gender Inequities in Infectious Diseases and Internal Medicine
An update on where women stand in academia, in specialties such as infectious diseases and internal medicine, and the disproportionate impact of the COVID-19 pandemic on women.
Breakthrough COVID-19 Risk Up for Patients With Substance Use Disorders
After controlling for lifetime comorbidities and adverse socioeconomic determinants of health, infection risk increased only for cannabis use disorder.
D-Dimer Level Not Useful for Ruling Out PE in COVID-19 Patients
Overall, 92.3 percent of patients had plasma D-dimer levels ≥0.05 µg/mL, including all with and 91.2 percent without, pulmonary embolism.
- Loading...
Loading...
Next post in COVID19
Loading... 
Loading...